Stock 002864 SHAANXI PANLONG PHARMACEUTICAL GROUP LIMITED BY SHARE LTD
Add to a list
To use this feature you must be a member
Log inSign up

Financials Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd

Equities

002864

CNE1000032C9

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 16/05/2024 am IST 		5-day change 1st Jan Change
30.05 CNY -0.53% Intraday chart for Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd -0.63% -21.93%
25/04 Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
25/04 Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: December 2022 2023 2024 2025
Capitalization 1 3,319 4,047 3,160 -
Enterprise Value (EV) 1 3,319 4,047 3,160 3,160
P/E ratio 33.2 x - - -
Yield - 0.57% 0.67% 0.67%
Capitalization / Revenue - 4.13 x 2.16 x 1.73 x
EV / Revenue - 4.13 x 2.16 x 1.73 x
EV / EBITDA - 24.6 x 14.6 x 11.7 x
EV / FCF - - - -
FCF Yield - - - -
Price to Book - 2.64 x 2.1 x 1.85 x
Nbr of stocks (in thousands) 85,557 1,05,155 1,05,155 -
Reference price 2 38.79 38.49 30.05 30.05
Announcement Date 21/04/23 25/04/24 - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025
Net sales 1 - 980.8 1,465 1,824
EBITDA 1 - 164.9 216.1 270.2
EBIT 1 - 134.9 196.2 251.4
Operating Margin - 13.75% 13.39% 13.78%
Earnings before Tax (EBT) - - - -
Net income 101.2 - - -
Net margin - - - -
EPS 1.170 - - -
Free Cash Flow - - - -
FCF margin - - - -
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share 2 - 0.2200 0.2000 0.2000
Announcement Date 21/04/23 25/04/24 - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025
Net Debt - - - -
Net Cash position - - - -
Leverage (Debt/EBITDA) - - - -
Free Cash Flow - - - -
ROE (net income / shareholders' equity) - 9.04% 8.87% 10.2%
ROA (Net income/ Total Assets) - - 8.9% 10.2%
Assets - - - -
Book Value Per Share 1 - 14.60 14.30 16.20
Cash Flow per Share 1 - 0.9800 1.480 2.100
Capex 2 - 62.4 10.6 14.4
Capex / Sales - 6.36% 0.72% 0.79%
Announcement Date 21/04/23 25/04/24 - -
1CNY2CNY in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
30.05 CNY
Average target price
41.72 CNY
Spread / Average Target
+38.84%
Consensus

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
SHAANXI PANLONG PHARMACEUTICAL GROUP LIMITED BY SHARE LTD Stock Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
-21.93% 44Cr
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.36% 69TCr
NOVO NORDISK A/S Stock Novo Nordisk A/S
+30.78% 59TCr
JOHNSON & JOHNSON Stock Johnson & Johnson
-1.60% 37TCr
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.07% 33TCr
ABBVIE INC. Stock AbbVie Inc.
+6.04% 29TCr
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.55% 24TCr
NOVARTIS AG Stock Novartis AG
+10.03% 21TCr
ROCHE HOLDING AG Stock Roche Holding AG
-3.03% 21TCr
AMGEN INC. Stock Amgen Inc.
+9.27% 17TCr
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 002864 Stock
  4. Financials Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW